Tendon & Ligament
Accelerated healing of Achilles tendon, MCL, and rotator cuff injuries in rat models with improved collagen fiber organization.
Chang et al. 2014≥99% Purity
BPC-157
Tissue Repair Studies
$60.00$30.00/vial with BOGO
USA madecGMP facility
QuantityBuy 1 Get 1 Free · auto-appliedAdd 2+ items to cart to activate the discount
Free Shipping on orders over $200
PASSEDSterility & Endotoxins
PASSEDNet Content & Purity
Researchers also added
Authenticity
Every vial is QR-authenticated
Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.
About this compound
BPC-157 is a synthetic peptide derived from a protein found in the stomach, best known in repair research for healing tissue and tendons, protecting the gut, and supporting recovery.
Synthetic pentadecapeptide (15 amino acids)
- Formula
- C62H98N16O22
- Molecular weight
- 1419.53 g/mol
- Form
- Lyophilized powder
- CAS / ID
- 137525-51-0
0+
Published Studies
Preclinical research papers
0
Amino Acid Sequence
Synthetic pentadecapeptide
0×
GHR Upregulation
Tendon fibroblasts by day 3
0
Research Areas
Tendon & Ligament · Gut Protection · Brain & Nervous System & more
How It Works
How BPC-157 works
The pathways BPC-157 acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
Angiogenesis & Vascular Support
VEGF Pathway
BPC-157 upregulates vascular endothelial growth factor (VEGF) expression, promoting new blood vessel formation and enhancing blood supply to injured tissue in preclinical models.
- Promotes blood vessel formation (angiogenesis)
- Enhances VEGF receptor expression
- Modulates nitric oxide signaling (NO system)
GHR Upregulation
Growth Hormone
Research demonstrates BPC-157 enhances growth hormone receptor expression in tendon fibroblasts by 7× within 3 days, supporting tissue repair signaling cascades.
- 7× growth hormone receptor upregulation
- Enhances tendon fibroblast viability
- Supports collagen synthesis signaling
Tissue Protection & Repair
Cytoprotective
BPC-157 demonstrates broad cytoprotective properties across multiple organ systems in animal studies, with particular relevance to gastrointestinal and musculoskeletal tissues.
- Gastric mucosal protection
- Accelerated wound closure in animal models
- Neuroprotective properties observed
Uses & Applications
What BPC-157 is researched for
The main areas BPC-157 is being studied for — and the study-reported figures behind them.
Gut Protection
Cytoprotective effects against NSAID-induced damage, alcohol lesions, and inflammatory bowel disease models.
Sikiric et al. 2011Brain & Nervous System
Demonstrated neuroprotective effects in traumatic brain injury and peripheral nerve damage models with improved recovery markers.
Sikiric et al. 2016Blood Vessel Repair
Promotes angiogenesis and accelerates blood vessel healing after surgical transection in animal models via NO system modulation.
Sikiric et al. 2019Molecular Structure
The BPC-157 molecule
An interactive 3D model rendered from the compound record — rotate and explore its structure.
C62H98N16O22
Third-Party Verified
Independently tested. Verifiably pure.
Every batch of BPC-157 is sent to an accredited independent laboratory before it ships. Here is what we screen for.
- HPLC Purity AnalysisConfirms the peptide is ≥99% pure
- Mass SpectrometryVerifies the exact molecular identity
- Heavy Metals ScreeningLead, arsenic, cadmium & mercury — Pass
- Endotoxins (LAL)Bacterial endotoxin levels — Pass
- Sterility TestingNo microbial contamination — Pass
- Net Peptide ContentActual peptide mass per vial verified
Certificate of Analysis · Freedom DiagnosticPASS
- HPLC Purity
- ≥99%
- Identity
- Mass-spec confirmed
- Endotoxin (LAL)
- Pass
- Net content
- Verified
Compound Information
Full specification
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Molecular Weight | 1419.53 Da |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Form | Lyophilized powder (5mg) |
| Purity | ≥99% (HPLC verified) |
| Testing | Third-party HPLC, Mass Spec, Endotoxin |
| Storage (Lyophilized) | -20°C for long-term stability |
| Storage (Reconstituted) | 2–8°C, use within 30 days |
| Solubility | Bacteriostatic water for reconstitution |
| COA | Included with every order |
FAQ
Common questions about BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a larger protein found in human gastric juice. It was discovered during research at the University of Zagreb, Croatia, and has been studied extensively in animal models for its tissue-protective and regenerative properties.
No. BPC-157 is not approved by the FDA or any regulatory agency for human use. It is classified as an unapproved drug. The FDA has issued warnings about BPC-157 being found in compounded products and dietary supplements. Only one Phase I clinical trial has been registered, and no Phase 2 or 3 trials have been completed.
Preclinical research (animal studies) has shown BPC-157 may accelerate healing of tendons, ligaments, muscles, and bones; protect the gastrointestinal tract from ulcers and inflammation; have neuroprotective effects in brain injury models; and promote blood vessel formation. All findings are from animal studies — no human clinical data exists.
In preclinical research, BPC-157 is typically reconstituted in bacteriostatic water and administered via intraperitoneal injection in rodent models. Research dosages range from 10 mcg/kg to 10 mg/kg depending on the study protocol and target tissue being investigated.
No lethal dose was reached in preclinical toxicology studies, and no significant adverse effects have been reported in published research. However, BPC-157 has never completed human clinical trials, so its safety profile in humans is unknown. It should only be used for in vitro laboratory research.
Lyophilized (powder) form should be stored at -20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 30 days. BPC-157 is remarkably stable — it resists hydrolysis, enzymatic degradation, and gastric acid.
Published Literature
Cited Sources
Peer-reviewed literature
Independent published research indexed from PubMed and peer-reviewed journals — not Eon Peptides claims.
[1]
PubMed
[2]Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract
View source PubMed
[3]Pentadecapeptide BPC 157 enhances growth hormone receptor expression in tendon fibroblasts
View source PubMed
[4]BPC 157 and NO system
View source PubMed
Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications
View source For Research Use Only.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.